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The DNA at the ends of linear chromosomes (the telomere) folds back onto itself
and forms an intramolecular lariat-like structure. Although the telomere loop has been
implicated in the protection of chromosome ends from nuclease-mediated resection
and unscheduled DNA repair activities, it potentially poses an obstacle to the DNA
replication machinery during S-phase. Therefore, the coordinated regulation of telomere
loop formation, maintenance, and resolution is required in order to establish a balance
between protecting the chromosome ends and promoting their duplication prior to cell
division. Until recently, the only factor known to influence telomere looping in human cells
was TRF2, a component of the shelterin complex. Recent work in yeast and mouse cells
has uncovered additional regulatory factors that affect the loop structure at telomeres.
In the following “perspective” we outline what is known about telomere looping and
highlight the latest results regarding the regulation of this chromosome end structure.
We speculate about how the manipulation of the telomere loop may have therapeutic
implications in terms of diseases associated with telomere dysfunction and uncontrolled
proliferation.
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INTRODUCTION
Telomeres protect the ends of chromosomes from being recog-
nized as DNA double-strand breaks (DSBs) and thereby prevent
the faulty repair of chromosome ends (de Lange, 2009). With
the evolution of linear genomes, cells were faced with the imme-
diate challenge of sequestering the exposed chromosome ends
away from DNA repair activities such as non-homologous end
joining (NHEJ) and homology directed repair (HDR). Many
present-day eukaryotes have developed several lines of defense
devoted to protecting telomeres from deleterious repair. Of these,
the best characterized are the telomere-associated proteinaceous
complexes such as shelterin, CST (Cdc13 (Ctc1)/Stn1/Ten1) and
the Ku70/80 heterodimer, which work in concert to ensure that
telomeres avoid being recognized as DSBs (Giraud-Panis et al.,
2010). Despite these measures, telomeric ends are nonetheless
subject to “controlled” exonuclease resection, which accounts for
the 3′ single stranded (ss) DNA overhang that is detectable at the
ends of many eukaryotic chromosome ends. As with other ssDNA
substrates, the telomeric overhang is, in theory, a highly recom-
binogenic intermediate that can potentially engage in illegitimate
recombination events with interstitial telomere repeats, resulting
in deleterious chromosome rearrangements. The exposed DNA
end is also at risk of being further processed by nuclease activ-
ities, which through the generation of ssDNA may activate a
potent DNA damage response (DDR) and drive the cell into irre-
versible cellular senescence. To prevent the telomeres from either
recombining or being exposed to nucleases, the telomeric 3′ over-
hang gets tucked away by forming a lasso-like fold-back structure,
whereby the overhang forms a displacement loop (D-loop) within
the telomeric tract (Griffith et al., 1999). Therefore the end gets
protected, but the loop structure does not bypass the need for
ss telomeric binding proteins, as they would in theory being
required to coat the displaced strand of the D-loop (see Figure 2
for illustration). In mammals, the telomere fold-back structure is
referred to as the t-loop, for telomeric loop. In terms of the evolu-
tion of linear chromosomes, it has been proposed that the t-loop
structure may represent the most primitive means of protect-
ing a telomere and likely arose before the protein-based telomere
capping complexes (de Lange, 2004). Fold-back structures have
been detected at telomeric DNA stemming from various organ-
isms, including: H. sapiens (Griffith et al., 1999), C. elegans
(Raices et al., 2008), S. pombe (Tomaska et al., 2004), S. cere-
visiae (Strahl-Bolsinger et al., 1997), P. sativum (Cesare et al.,
2003) and T. brucei (Munoz-Jordan et al., 2001). Although the
most parsimonious model for the t-loop would be that it is pro-
viding an additional level of end-protection in conjunction with
the capping complexes, the evidence to date remains correla-
tive. The lack of understanding regarding t-loop function stems
from the fact that they have been extremely difficult to detect
in vivo in a reliable and quantitative manner, and as a result,
little has been reported regarding their molecular dependencies
in terms of establishment and/or maintenance. Details pertain-
ing to: in vivo t-loop regulation through the cell cycle, during
telomerase-mediated elongation, or at dysfunctional telomeres
remains elusive. In spite of the in vivo shortcomings related to
t-loop detection there have been many intriguing models and
speculations focused on how t-loops may be regulated during the
above-mentioned processes. For example, it has been proposed
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that such a structure has to be resolved in S-phase to allow passage
of the replication fork (Vannier et al., 2012). It is also perceivable
that telomerase, the reverse transcriptase that elongates telomeres,
would require an “open” structure in order to facilitate inter-
action with the overhang before the elongation reaction ensues
(de Lange, 2004). Finally, although in general HDR is suppressed
at telomeres, there are pathological situations where it replaces
telomerase as the mode of telomere elongation. Indeed, alterna-
tive lengthening of telomeres (ALT) tumor cells maintain their
telomeres via recombination, and it is likely that t-loops have to be
opened to engage in HDR with either t-circles or other telomeres
(Tomaska et al., 2009). Another very plausible possibility, how-
ever, would be that the invading 3′ overhang of the t-loop gets
extended within the loop itself. Such an intrachromosomal HDR
event would not necessarily require loop opening (Tomaska et al.,
2009).
Many of these models are based on compelling data derived
from a combination of in vitro and, to a lesser extent, in vivo
experiments. In this perspective we will primarily focus on recent
reports in human cells and budding yeast that have introduced
new players with respect to the control of telomere loop forma-
tion. Furthermore, we will speculate on how the regulation of the
telomere loop structure needs to be tightly controlled and how it
may even provide a relevant target in terms of therapy for diseases
associated with deregulated telomere function.
MAMMALIAN T-LOOPS
T-loops were first reported upon their visualization by electron
microscopy on DNA extracted from human and mouse cells
(Griffith et al., 1999; Nikitina and Woodcock, 2004). In vitro, the
telomeric DNA binding protein TRF2 is sufficient to promote
t-loop formation (Stansel et al., 2001), although in vivo addi-
tional factors are likely to be involved (Verdun and Karlseder,
2006). Since TRF1 is able to bend telomeric repeats (Bianchi et al.,
1997) and can pair telomeric tracts in vitro (Griffith et al., 1998),
TRF1 is likely to assist loop formation in vivo. It was proposed
that TRF1 bends and pairs telomeric duplexes back onto them-
selves and therefore facilitates strand invasion, catalyzed by TRF2
(Griffith et al., 1999). ssDNA binding protein was detected at the
loop junction, arguing that an invasion of the 3′ ssDNA overhang
into telomeric double-stranded DNA was occurring and displac-
ing the telomeric duplex (Griffith et al., 1999). Consistently, the
presence of a single strand overhang is required for t-loop for-
mation/maintenance in vitro (Griffith et al., 1999). Moreover,
the recombinogenic proteins RAD51 and RAD52 are present at
telomeres during the S/G2 phases of the cell cycle (Verdun and
Karlseder, 2006). Strikingly, nuclear extracts from synchronized
cells are able to promote in vitro telomeric D-loop formation in
a RAD51 and RAD52 dependent manner primarily in the S/G2
phases of the cell cycle (Verdun and Karlseder, 2006). The size
distribution of t-loops ranges from 3 to 25 kb for HeLa cells and
correlates roughly with telomere length. It still remains unclear
whether all telomeres carry a t-loop and whether this structure is
opened in a cell cycle dependant manner, i.e., to allow the replica-
tion fork to pass or to allow telomerase elongation events. One
can imagine that a helicase with the ability to resolve D-loops
would be an ideal candidate for opening a t-loop when required.
Recently, it has been shown that the conserved mouse helicase
RTEL1 (regulator of telomere length 1) can undo t-loops in vitro
(Vannier et al., 2012). In this report, Vannier et al. also reported an
accumulation of extra-telomeric circles (t-circles) and increased
telomere loss events upon the Cre-mediated removal of RTEL1.
They proposed that in the absence of RTEL1, unresolved t-loops
accumulate and get processed by the SLX4 nuclease complex
when encountered by the DNA replication machinery, thereby
liberating a telomere circle and leaving the chromosome end void
of telomeric sequence. An independent study reported that the
loss of RTEL1 in mouse embryonic stem cells led to gradual
telomere shortening, which suggested that RTEL1 loop opening
might also be required for telomerase elongation (Uringa et al.,
2012). The latter study, however, did not detect increased t-circles
upon RTEL1 loss.
Taken together, these data imply that a very intricate temporal
regulation must take place upon telomere replication. On the one
hand, the t-loop must be opened (possibly by the RTEL1 helicase)
upon passage of the replication fork in order to avoid replica-
tion collapse and SLX4-mediated generation of t-circles/telomere
loss. Loop opening also liberates the 3′ ss overhang that may get
extended by telomerase. On the other hand, upon the comple-
tion of telomeric replication, the HDR machinery should gain
access to the telomere and promote t-loop formation, presum-
ably to maintain telomere protection (see Figure 1). The balance
between t-loop resolving and t-loop forming activities must be
tightly regulated and presumably depends on rapid and reversible
post-translational modifications of the proteins involved. RTEL1,
for example, would have to be rapidly removed from telomeres
following replication in order to ensure that t-loops can be re-
established and are not constitutively unwound. Consistently, it
was suggested that RTEL1 is only able to transiently associate with
telomeres, however, the mode of regulation remains unknown
(Uringa et al., 2012).
YEAST FOLD-BACK STRUCTURE
For optimal visualization, the TTAGGG repeats of mammalian
telomeres were cross-linked by psoralen to prevent branch
migrating enzymes from undoing the structures. Looking at
telomere fold-backs in S. cerevisiae (Sc) is complicated by the
fact that the yeast telomere repeat sequence lacks a TA step and
therefore crosslinking by psoralen before electron microscopy
is not possible (de Lange, 2004). Furthermore, yeast telomeres
are significantly smaller in size than mammalian telomeres and
therefore more difficult to both isolate and visualize. It has been
speculated that budding yeast may not have a true telomeric loop
due to the absence of TRF1/2-like telomeric proteins, which seem
to play a critical role in human t-loop establishment (Tomaska
et al., 2004). Furthermore, due to the small size of yeast telomeres,
there may be physical restraints on looping back into the telom-
eric region, which on average is a mere 400 bp in comparison with
the approximately 10 kbp telomeres of human cells. Despite these
“shortcomings” there is increasing evidence to suggest that the
telomeres of budding yeast do indeed loop back, although the
molecules involved and the mechanistic details may differ.
Although the TRF1 and TRF2 proteins are absent in bud-
ding yeast, compensation has been achieved by uniting the TRF1,
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FIGURE 1 | T-loop regulation may require precise temporal regulation.
The displacement loop likely inhibits the smooth passage of the DNA
replication machinery upon telomere replication. It has been suggested that
the RTEL1 helicase is able to resolve the t-loop structure and allow replication
fork passage while at the same time providing telomerase access to the 3′ ss
overhang. In the absence of RTEL1 the replication machinery may encounter
the t-loop junction, resulting in fork stalling and the subsequent
SLX4-mediated excision of a t-circle, which leads to rapid telomere loss. In
this situation (RTEL absent) the loss is compounded by the inability of
telomerase to act. Upon the completion of telomere replication the loop must
be re-established. Therefore, a complete switch from t-loop resolving to
t-loop promoting activities must take place. As the HDR factors RAD51 and
RAD52, which are necessary for t-loop formation, get loaded onto telomeres,
we suggest that RTEL1 must get actively removed. Together these activities
would sequentially promote telomere replication, telomerase elongation, and
the re-establishment of a protective loop structure.
TRF2, and RAP1 functions into the single Rap1 protein. Indeed,
unlike its human counterpart, budding yeast Rap1 binds telom-
eric DNA directly via its Myb domain. Furthermore, Rap1, like
TRF1, has the ability to bend and reshape DNAmolecules (Gilson
et al., 1993). Finally, Rap1 is also essential to prevent telom-
ere dysfunction resulting from exonuclease-mediated resection
(Vodenicharov et al., 2010), chromosome end fusions (Pardo and
Marcand, 2005) as well as rapid telomere deletions (Li and Lustig,
1996). Although yeast Rap1 directly binds only 300 bp of telom-
eric DNA at the end of the chromosome, it was found in chro-
matin immunoprecipitation (ChIP) experiments to be associated
with subtelomeric regions up to 2 kb away from the telomere,
despite the fact that chromatin was sheared to 500 bp fragments
or less (Strahl-Bolsinger et al., 1997; Poschke et al., 2012). These
experiments suggest that yeast telomeres fold back onto them-
selves and into the subtelomeric region. A clever genetic trick
with a transcriptional readout was employed by the Ptashne lab
to further demonstrate a fold-back structure in budding yeast
(de Bruin et al., 2001). They modified a telomere so that the
URA3 gene was followed at its 3′ end by the GAL4 UAS (upstream
activating sequence), which was in turn followed by the telom-
ere (de Bruin et al., 2000, 2001). They demonstrated that in the
presence of galactose URA3 transcription was induced, suggest-
ing that the UAS was folding back and activating the natural
URA3 promoter. They confirmed this physical interaction by
ChIP and went on to show that the transcriptional activation
of URA3 by a downstream UAS was specific to its telomeric
localization, where looping back was favored. Interestingly, the
fold-back structure at telomeres required the Sir2 lysine deacety-
lase (KDAC) complex. Subsequently, it has been observed that
Cdc13, which binds to the telomeric 3′ overhang in yeast, can
also precipitate subtelomeric DNA up to 1.5 kb away from the
end despite extensive chromatin shearing. Ku70 has also been
implicated in the establishment of telomeric loops in budding
yeast (Pryde and Louis, 1999). Taken together, these experiments
strongly suggest that yeast telomeres fold back into a loop-like
structure.
Despite the increasing body of evidence demonstrating
telomere fold-backs in yeast, it remains unclear as to whether
the fold-back structure at budding yeast telomeres is equiva-
lent to mammalian t-loops. Firstly, all of the above mentioned
experiments suggest that yeast telomeres fold-back into the sub-
telomere, in contrast to mammalian t-loops that are exclusively
comprised of telomere repeat containing DNA. The subtelomeric
fold-backmay be a requirement due to the shorter yeast telomeres
combined with a minimal length requirement for loop forma-
tion. It should be noted that yeast subtelomeres contain multiple
telomeric repeat sequences throughout their entirety, therefore
the 3′ overhang would, in theory, have an ample supply of homol-
ogous sequences to basepair with. However, the dependency on
the 3′ overhang and whether a displacement loop even exists at
yeast telomeres has not been addressed. Our preliminary data
suggest that in contrast to human t-loops, RAD52, RAD51, and
RAD50 appear to be dispensable for fold-back formation in yeast
(Sarah Luke-Glaser and Brian Luke, unpublished data). Due to
these striking differences, we refrain from referring to the yeast
fold-back at telomeres as a t-loop. Although there are mechanis-
tic differences related to loop establishment between yeast and
man, the loop may indeed have similar protective properties for
chromosome ends.
The yeast helicase Mph1 was proposed to be the functional
homolog of mouse RTEL1 as it has the same enzymatic prop-
erties in vitro (Uringa et al., 2011). Interestingly, overexpressed
Mph1 promotes rapid cellular senescence in yeast mutants lack-
ing telomerase activity (Luke-Glaser and Luke, 2012). As Mph1
can disassemble D-loops, the proposed intermediate of a t-loop,
in vitro, we proposed that Mph1 overexpression may be opening
the fold-back structure and exposing telomere ends to nucleolytic
attack. Consistently, in telomerase mutants Mph1 overexpres-
sion led to increased ssDNA at the telomere and was highly
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toxic in mutants that were compromised for telomere capping.
Overexpression of Mph1 in wild type cells did not have any
obvious telomere dysfunction phenotypes. Together, these data
would be in line with a model whereby Mph1 would undo a fold-
back structure at the telomere, but that telomeres only become
completely dysfunctional once they also lack capping function
(Figure 2). We propose that telomeric binding proteins such as
the CST and KU-complex are the first line of defense and that a
higher order structure such as a fold-back acts in parallel to keep
telomeres in a protected state.
In order to gain a more global perspective of the genetic
requirements for telomere looping, Poschke et al. (2012) used
the above-describedURA3 looping reporter and screened the col-
lection of viable yeast deletions for mutants that were unable to
induce URA3 transcription. This approach yielded 112 candi-
date genes that were defective for telomere looping. Many of the
candidates were further confirmed to be looping defective with
Rap1 and Cdc13 ChIP assays, as described above. This exper-
iment revealed that the Rap1 associated factors Rif1 and Rif2
were both looping defective; furthermore, the telomere associ-
ated KDACs Rpd3, Hda1, and Sir2 were also found to be defective
for loop formation. Intriguingly, the mutants on their own had
only mild telomere dysfunction phenotypes, which were syn-
ergistically exacerbated upon either inhibition of telomerase or
inactivation of telomere capping proteins. This is consistent with
what was reported when Mph1 was overexpressed and supports
the notion that protein-mediated telomere capping and telom-
ere looping may promote end protection in parallel pathways
(Figure 2). In addition to the KDAC complexes that were found
in the yeast telomere looping screen, there were a surprising num-
ber of genes implicated in diverse biological functions ranging
from chromatin remodeling to metabolic signaling to translation
regulation. Indeed, it is likely that the effects on telomere loop-
ing in the majority of these mutants are indirect, however, this
range of biological pathways that converge on telomere structure
opens the door to many possibilities in terms of manipulating
the loop structure (see below). It will be interesting to deter-
mine how many of these pathways also affect telomere function
in vertebrates.
FUTURE PERSPECTIVES—LOOP CONTROL
Targeting telomeres and telomerase for therapeutic purposes is
by no means a novel concept. Since all cancer cells rely on
continuous telomere maintenance (through either telomerase
activation or HDR), it has been suggested that the inhibition
of telomere maintenance may cripple their “immortal” proper-
ties and drive them into cellular senescence. As cancer cells are
highly proliferative and, in general, have shorter telomeres than
non-oncogenic cells, it was postulated that such therapy would
preferentially target tumor cells. The drawbacks associated with
the inhibition of telomere maintenance are: (1) The telomeres
may not shorten fast enough in the tumor environment to have
FIGURE 2 | Parallel pathways may promote end protection. We
speculate that a fully protected telomere (top) exists when the telomere is
folded back and the 3′ ssDNA overhang is engaged in a D-loop (not yet
shown for yeast). The remaining ss telomeric DNA would then be coated
by the organism-specific ss telomeric binding proteins (as depicted here for
human and S. cerevisiae) to prevent excessive resection and checkpoint
activation (capping). When either looping or capping is compromised, the
chromosome ends become more vulnerable to resecting nucleases
(middle), while some protection is maintained. The simultaneous loss of
looping and capping renders telomeres completely open to resection and
eventually DNA repair activities, which can lead to chromosome fusions and
genome instability.
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an effect on cell viability and (2) the inhibition of telomerase
may eventually select for cells that maintain telomeres through
HDR (ALT cells). Indeed, a recent study using a mouse tumor
model has demonstrated that telomerase inhibition does ini-
tially lead to tumor shrinkage, however, this is followed by a
relapse whereby the tumor re-grows and in a more aggressive
manner (Hu et al., 2012). Upon examining the telomere sta-
tus in these “relapsed tumors,” it was determined that they had
engaged the ALT pathway of telomere maintenance. Therefore,
using telomerase inhibitors for cancer therapy may be more effec-
tive when combined with a means to increase the rate of telomere
loss/resection. This combined therapy would have the advantage
of eliminating the “lag time” associated with telomere shorten-
ing and furthermore may decrease the window of opportunity for
ALT to develop.
Studies in yeast have been able to establish strong corre-
lations between loss of the telomere fold-back structure and
increased rates of telomere loss/resection (Poschke et al., 2012)
(see above). This suggests that inhibition of the t-loop in com-
bination with telomerase inhibition may result in accelerated
telomere loss/resection and thereby promote the rate of senes-
cence in highly proliferative cells where telomere maintenance is
essential. Such an approach may also prevent the re-occurrence
of ALT cells by: (1) Giving ALT less time to initiate and (2)
reducing the amount of t-circles, which have been proposed to
arise via t-loop resolution and may act as substrates for HDR
mediated telomere elongation. The above-described screen for
looping defective yeast mutants may provide a starting block
for candidate pathways/molecules that could be either inhibited
or activated to inhibit telomere looping. KDACs, for example,
emerge as prime candidates due to their high degree of conser-
vation and the availability of small molecule KDAC inhibitors
(Khan and La Thangue, 2012). In yeast it has been shown that
loss of Rpd3 function (mammalian KDAC1) leads to a loop-
ing defect and subsequently to rapid onset of senescence in the
absence of telomerase. It was also observed that these mutants
were delayed in forming survivors (the yeast ALT equivalent)
(Dees and Luke, unpublished data). Of course it remains to
be tested whether or not the regulators of telomere looping in
yeast are also responsible for modulating the t-loop structure in
mammals.
Both RTEL1 and yeast Mph1 have been implicated in telomere
function, potentially through the regulation of loop structures.
Understanding the regulation of these factors at telomeres may
also provide means to manipulate t-loops in conjunction with
telomerase inhibition. Whereas the inactivation of RTEL1 leads
to accelerated telomere loss due to the inability to resolve t-loops,
the over-expression of Mph1 may lead to telomere dysfunction
through constitutive loop opening. Indeed, both the hyper- and
hypo-activation of RTEL1/Mph1 could be combined with loss of
telomerase to promote senescence.
In summary, as we learn more about how telomere structure is
established and maintained, we increase the possibilities available
for telomere-based therapies. Such therapies could be particularly
beneficial to limit the spread of cancer cells where telomere length
maintenance is required for continued proliferation.
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